News & Press Releases

CELLERANT THERAPEUTICS, INC. AWARDED $6.86 MILLION GRANT FROM CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE TO SUPPORT DEVELOPMENT OF NOVEL ANTIBODY- DRUG CONJUGATE FOR AML
August 22, 2017


 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.